Epilepsy is a neurological disease that is characterized as unpredictable seizures as well as other health problems. A CBD product has received FDA approval in the treatment of two rare kinds of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. This drug, Epidiolex which is 99% pure CBD, was found to be effective in reducing the frequency of seizures of patients. This FDA approval shows there is strong enough evidence for CBD to be an effective treatment for two forms of epilepsy. Other CBD studies have shown potential for other forms of epilepsy, but have yet to reach FDA approval.

​

Epilepsy CBD Research

​

• The cannabinoids as potential antiepileptics.

• Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.

• Charlotte's Web and Zaki's Journey (Youtube Video)

• Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.